US Patent 7951809 Inhibitors of p38
Patent 7951809 was granted and assigned to Vertex Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+439 characters)
Article
Patent abstract
The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07951809 Inhibitors of p38 US Patent 7951809 Inhibitors of p38
Infobox
Patent Number
0795180900
Patent Number
795180900
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079518090
Date of Patent
May 31, 2011
0Patent Application Number
120624950
Date Filed
April 3, 2008
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079518090
Date of Patent
May 31, 2011
0Patent Application Number
120624950
Date Filed
April 3, 2008
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07951809 Inhibitors of p38
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07951809
Date of patent
May 31, 2011
Patent application number
12062495
Date Filed
April 3, 2008
Patent primary examiner
Find more entities like US Patent 7951809 Inhibitors of p38
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
